Any Gene to Any Cell
SIRION Biotech Viral Vector Technologies from vector engineering and production to gene therapy and immune-oncology development.SIRION Biotech’s Viral Vector Technologies
SIRION Biotech improves transduction & performance of your viral vector strategies.
SIRION Biotech is the only company mastering custom optimization of all 3 major virus types that are used regularly for genetic modification of mammalian cells.
Customized viral vectors and cell models – highest quality standards and QC
Detailed & precise time management – stick to your project plans, meet your deadlines
Personalized multilingual project management and consulting – our expertise with your goals in mind
Technology features
Multicistronic (all-in-one) Lentivirus, AAV and Adenovirus engineering and production, largely with proprietary IP
Full expression control with inducible or tissue specific promoters and specialized transduction boosters
Ability to work as next generation technology R&D partners to generate new intellectual properties and excel the precision of your therapy development
Licensing options for existing in-house technologies are available.
SIRION Biotech is globally, with a strong customer base in cancer research, neurosciences, regenerative medicines, gene therapy, CAR-T cell development and new vaccination methods.
With OVER 500 projects for more than 150 repeat clients, SIRION Biotech understands the technical challenges of your work.
